Cargando…

Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM

The pathogenesis of MYBPC3-associated hypertrophic cardiomyopathy (HCM) is still unresolved. In our HCM patient cohort, a large and well-characterized population carrying the MYBPC3:c772G>A variant (p.Glu258Lys, E258K) provides the unique opportunity to study the basic mechanisms of MYBPC3-HCM wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pioner, Josè Manuel, Vitale, Giulia, Steczina, Sonette, Langione, Marianna, Margara, Francesca, Santini, Lorenzo, Giardini, Francesco, Lazzeri, Erica, Piroddi, Nicoletta, Scellini, Beatrice, Palandri, Chiara, Schuldt, Maike, Spinelli, Valentina, Girolami, Francesca, Mazzarotto, Francesco, van der Velden, Jolanda, Cerbai, Elisabetta, Tesi, Chiara, Olivotto, Iacopo, Bueno-Orovio, Alfonso, Sacconi, Leonardo, Coppini, Raffaele, Ferrantini, Cecilia, Regnier, Michael, Poggesi, Corrado
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977265/ https://www.ncbi.nlm.nih.gov/pubmed/36744470 http://dx.doi.org/10.1161/CIRCRESAHA.122.321956

Ejemplares similares

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
por: Pioner, Josè Manuel, et al.
Publicado: (2022)

Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle
por: Scellini, Beatrice, et al.
Publicado: (2021)

R4496C RyR2 mutation impairs atrial and ventricular contractility
por: Ferrantini, Cecilia, et al.
Publicado: (2016)

The relation between sarcomere energetics and the rate of isometric tension relaxation in healthy and diseased cardiac muscle
por: Vitale, Giulia, et al.
Publicado: (2019)

Late sodium current inhibitors to treat exercise‐induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium
por: Ferrantini, Cecilia, et al.
Publicado: (2018)

Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency
por: Pioner, Josè Manuel, et al.
Publicado: (2022)

Corrigendum: Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: the impact of full-length dystrophin deficiency
por: Pioner, Josè Manuel, et al.
Publicado: (2023)

Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models
por: Ferrantini, Cecilia, et al.
Publicado: (2017)

A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study
por: Woulfe, Kathleen C., et al.
Publicado: (2019)

Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside
por: Palandri, Chiara, et al.
Publicado: (2022)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study
por: Coppini, Raffaele, et al.
Publicado: (2019)

The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM
por: Piroddi, Nicoletta, et al.
Publicado: (2019)

Optical Investigation of Action Potential and Calcium Handling Maturation of hiPSC-Cardiomyocytes on Biomimetic Substrates
por: Pioner, Josè Manuel, et al.
Publicado: (2019)

Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function
por: Coppini, Raffaele, et al.
Publicado: (2022)

Regulation of intracellular Na(+) in health and disease: pathophysiological mechanisms and implications for treatment
por: Coppini, Raffaele, et al.
Publicado: (2013)

T-tubule remodeling in human hypertrophic cardiomyopathy
por: Vitale, Giulia, et al.
Publicado: (2020)

α-Tropomyosin with a D175N or E180G Mutation in Only One Chain Differs from Tropomyosin with Mutations in Both Chains
por: Janco, Miro, et al.
Publicado: (2012)

Altered Ca(2+) and Na(+) Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis
por: Coppini, Raffaele, et al.
Publicado: (2018)

Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy
por: Crocini, C., et al.
Publicado: (2016)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center
por: Mazzarotto, Francesco, et al.
Publicado: (2018)

Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy
por: Pioner, Josè Manuel, et al.
Publicado: (2020)

T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure
por: Crocini, Claudia, et al.
Publicado: (2016)

Impact of detubulation on force and kinetics of cardiac muscle contraction
por: Ferrantini, Cecilia, et al.
Publicado: (2014)

Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
por: Coppini, Raffaele, et al.
Publicado: (2014)

Myocardial fibrosis comparison by cmr between genetically positive HCM patients with MYBPC3 and MYH7 gene mutations
por: Villanueva, Alejandra, et al.
Publicado: (2015)

Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation
por: Crocini, Claudia, et al.
Publicado: (2016)

Pharmacological Inhibition of Serine Proteases to Reduce Cardiac Inflammation and Fibrosis in Atrial Fibrillation
por: Coppini, Raffaele, et al.
Publicado: (2019)

Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes
por: Schuldt, Maike, et al.
Publicado: (2021)

Alpha and beta myosin isoforms and human atrial and ventricular contraction
por: Walklate, Jonathan, et al.
Publicado: (2021)

Histopathology in HCM
por: Tejado, Beatriz San Millán, et al.
Publicado: (2018)

Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
por: Helms, Adam S., et al.
Publicado: (2020)

Ablation of palladin in adult heart causes dilated cardiomyopathy associated with intercalated disc abnormalities
por: Mastrototaro, Giuseppina, et al.
Publicado: (2023)

Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation
por: Thompson, Andrea D., et al.
Publicado: (2021)

Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry
por: Girolami, Francesca, et al.
Publicado: (2022)

Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms
por: Biasci, V., et al.
Publicado: (2022)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
por: Passini, Elisa, et al.
Publicado: (2016)

Myopalladin knockout mice develop cardiac dilation and show a maladaptive response to mechanical pressure overload
por: Filomena, Maria Carmela, et al.
Publicado: (2021)

Follow-up and prognosis of HCM
por: Dominguez, Fernando, et al.
Publicado: (2018)

Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex
por: Santini, Lorenzo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ed9fjimfto45tvvbusv0kfdsr